J. Goldman & Co’s Allergan Inc AGN Stock Holding History

J. Goldman & Co’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-7,600	Closed	-$1.62M	–	355
2014 Q4	$1.62M	Sell	7,600 -9,900	-57%	-$1.97M	0.19%	130
2014 Q3	$3.12M	Sell	17,500 -27,700	-61%	-$4.6M	0.19%	145
2014 Q2	$7.65M	Buy	+45,200	New	+$7.04M	0.56%	47
2014 Q1	–	Sell	-22,500	Closed	-$2.5M	–	367
2013 Q4	$2.5M	Buy	+22,500	New	+$2.15M	0.31%	100

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

J. Goldman & Co's AGN Position: Q1 2015 in Review

J. Goldman & Co sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 101,717 shares — an estimated $21.6M sold.

J. Goldman & Co first reported a position in AGN in Q2 2014 and held it in 3 quarters. The position peaked at $21.6M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

J. Goldman & Co reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
J. Goldman & Co sold 101,717 Allergan Inc shares in Q1 2015, an estimated $21.6M.
J. Goldman & Co first reported a position in Allergan Inc in Q2 2014 and held it in 3 quarters.
J. Goldman & Co's Allergan Inc position peaked at $21.6M in Q4 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on J. Goldman & Co's 13F filing for Q1 2015, filed 18 May 2015.